Trial‐generated profiles for implantation of electrical devices in outpatients with heart failure: real‐world prevalence and 1‐year outcome

As many as half the IN-CHF outpatients fulfilled current criteria for device implantation. Various subgroups had higher 1-year mortality than patients in trial control arms - a finding that may not be entirely attributable to differences in drug therapy (especially beta blockers).